These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19407441)

  • 1. Factors influencing uptake of pharmacogenetic testing in a diverse patient population.
    O'Daniel J; Lucas J; Deverka P; Ermentrout D; Silvey G; Lobach DF; Haga SB
    Public Health Genomics; 2010; 13(1):48-54. PubMed ID: 19407441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public perceptions of pharmacogenetics.
    Zhang SC; Bruce C; Hayden M; Rieder MJ
    Pediatrics; 2014 May; 133(5):e1258-67. PubMed ID: 24777223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
    Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of US public attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
    Pharmacogenomics J; 2012 Jun; 12(3):197-204. PubMed ID: 21321582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and physicians' perspectives on pharmacogenetic testing.
    Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
    Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
    Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
    Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
    Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest in BRCA1/2 testing in a primary care population.
    Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
    Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
    Stanek EJ; Sanders CL; Taber KA; Khalid M; Patel A; Verbrugge RR; Agatep BC; Aubert RE; Epstein RS; Frueh FW
    Clin Pharmacol Ther; 2012 Mar; 91(3):450-8. PubMed ID: 22278335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
    Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
    Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada.
    Bashir NS; Ungar WJ
    Genome; 2015 Dec; 58(12):527-40. PubMed ID: 26623513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease.
    Morren M; Rijken M; Baanders AN; Bensing J
    Patient Educ Couns; 2007 Feb; 65(2):197-204. PubMed ID: 16939709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumers' views of pharmacogenetics--A qualitative study.
    Haddy CA; Ward HM; Angley MT; McKinnon RA
    Res Social Adm Pharm; 2010 Sep; 6(3):221-31. PubMed ID: 20813335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.
    Mowbray C; Turner J; Gai J; Jacobs S
    J Pediatr Hematol Oncol Nurs; 2022; 39(3):168-177. PubMed ID: 35467433
    [No Abstract]   [Full Text] [Related]  

  • 17. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diffusion of innovation: factors influencing the uptake of pharmacogenetics.
    Nielsen LF; Moldrup C
    Community Genet; 2007; 10(4):231-41. PubMed ID: 17895629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
    Haga SB; Mills R; Moaddeb J
    Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.